In The News: School of Integrated Health Sciences
Most ARIA cases are mild, but some have been fatal
Recently approved disease-modifying treatments for Alzheimer's disease have created a sudden demand, but these and other drugs in the pipeline are not for all patients with clinical Alzheimer's symptoms, experts said.
The ºÚÁÏÍø food pantry is teaming up with Three Square to host a free food drive.
COVID-19’s latest variant is on the loose, but local experts think vaccines can mitigate its spread and severity.
Looking ahead to 2024 and beyond: "There is so much more to be done"
Backwards running may sound ridiculous, but studies show it has benefits for both brain and body
Over the past year, the field has experienced another significant leap of growth, powered by advances in translational research and capped off by the approval of lecanemab (Leqembi; Eisai), the first traditionally approved therapy in nearly two decades.
After decades of failed trials, ineffective drugs and billions of dollars spent, a new frontier of shots offer a glimmer of hope for current and future sufferers of the cruel condition that affects 5.8million Americans.
The positive results are expected to form the basis for further development of Lomecel-B as a potential treatment for mild AD
The ºÚÁÏÍø food pantry is not only supplying food to those on campus but also food safety education and healthy options that may be costly to come by.
Over the past 50 years, attention deficit/hyperactive disorder — more commonly known as ADHD — has evolved from a little-known condition into arguably the most studied disorder in the field of child psychiatry.
Recent studies validate the benefits of retroactive locomotion in reducing low back pain and pressure on joints. However, doing this activity without following the instructions of a guide or without any supervision can increase the risk of injuries and falls.